Pre-Market Stock News (APR 25, 2007)

(ABN) ABN AMRO gets a higher bid of roughly $98 Billion (13% higher than Barclays) from a group led by Royal Bank of Scotland.
(ABC) Amerisource Bergen raised guidance after earnings.
(AMZN) Amazon.com traded up more than 10% after beating earnings and solid guidance.
(ASH) Ashland $0.77 EPS vs $0.84e; unsure if comparable because net after discontinued operations was $0.49e.
(BA) Boeing $1.13 EPS vs. $1.02 Estimate; $262 Billion backlog; reaffirmed 2007-2008 guidance.
(CL) Colgate names its COO as CEO.
(DRI) Darden Restaurants Inc. would be a good private equity target according to Cramer.
(FCX) Freeport-McMoRan $2.02 EPS vs $2.09e; insure of comparable because of Phelps Dodge acquisition completing at end of quarter.
(GD) General Dynamics $1.07 EPS vs $1.05e.
(GLW) Corning $0.28 EPS ($0.20 after special items) vs $0.26e; guides next quarter to $0.30-0.33 EPS vs $0.30 est; stock up 3%.
(GSK) GlaxoSmithKline reported flat profits, partially hurt by weaker dollar sales.
(HCR) Manor Care $0.39 EPS vs $0.30e.
(KTO) K2 being acquired by Jarden (JAH) for roughly $15.50 total: will pay $10.85 per share and will pay 0.1086 JAH shares per KTO share.
(PEP) PepsiCo $0.65 EPS vs $0.61e; revenues $7.35 Billion vs. $7.18B(e).
(RTN) Raytheon $0.69 EPS vs $0.63; 2.85-3.00 vs $3.01e.
(SUNW) Sun Microsystems down 6% after $0.01 EPS vs $0.01e; but revenues tad light at $3.28 B vs $3.42B(e); looking for 15-18% revenue growth in Q4, short of the 22% expected rise.
(SRZ) Sunrise names new CFO after prior CFO Bradley was put on leave after broken rules on document retention.
(TFSM) 24/7 Real Media may be in talks with WPP Group in London over a $600 million acquisition after the Google-DoubleClick deal.
(TRB) Tribune launches a $34 share buyback in partial tender.
(UPS) UPS $0.96 EPS vs $0.96e.
(WFT) Weatherford $0.82 EPS vs $0.78e.
(WLP) WellPoint $1.26 EPS as expected; raised guidance, but the “raised” looks in-line or even a tad under estimates.
(WYE) Wyeth received an approvable letter from FDA for Bazedoxifene for the prevention of postmenopausal osteoporosis.

Jon C. Ogg
April 25, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.(ABN) ABN AMRO gets a higher bid of roughly $98 Billion (13% higher than Barclays) from a group led by Royal Bank of Scotland.
(ABC) Amerisource Bergen raised guidance after earnings.
(AMZN) Amazon.com traded up more than 10% after beating earnings and solid guidance.
(ASH) Ashland $0.77 EPS vs $0.84e; unsure if comparable because net after discontinued operations was $0.49e.
(BA) Boeing $1.13 EPS vs. $1.02 Estimate; $262 Billion backlog; reaffirmed 2007-2008 guidance.
(CL) Colgate names its COO as CEO.
(DRI) Darden Restaurants Inc. would be a good private equity target according to Cramer.
(FCX) Freeport-McMoRan $2.02 EPS vs $2.09e; insure of comparable because of Phelps Dodge acquisition completing at end of quarter.
(GD) General Dynamics $1.07 EPS vs $1.05e.
(GLW) Corning $0.28 EPS ($0.20 after special items) vs $0.26e; guides next quarter to $0.30-0.33 EPS vs $0.30 est; stock up 3%.
(GSK) GlaxoSmithKline reported flat profits, partially hurt by weaker dollar sales.
(HCR) Manor Care $0.39 EPS vs $0.30e.
(KTO) K2 being acquired by Jarden (JAH) for roughly $15.50 total: will pay $10.85 per share and will pay 0.1086 JAH shares per KTO share.
(PEP) PepsiCo $0.65 EPS vs $0.61e; revenues $7.35 Billion vs. $7.18B(e).
(RTN) Raytheon $0.69 EPS vs $0.63; 2.85-3.00 vs $3.01e.
(SUNW) Sun Microsystems down 6% after $0.01 EPS vs $0.01e; but revenues tad light at $3.28 B vs $3.42B(e); looking for 15-18% revenue growth in Q4, short of the 22% expected rise.
(SRZ) Sunrise names new CFO after prior CFO Bradley was put on leave after broken rules on document retention.
(TFSM) 24/7 Real Media may be in talks with WPP Group in London over a $600 million acquisition after the Google-DoubleClick deal.
(TRB) Tribune launches a $34 share buyback in partial tender.
(UPS) UPS $0.96 EPS vs $0.96e.
(WFT) Weatherford $0.82 EPS vs $0.78e.
(WLP) WellPoint $1.26 EPS as expected; raised guidance, but the “raised” looks in-line or even a tad under estimates.
(WYE) Wyeth received an approvable letter from FDA for Bazedoxifene for the prevention of postmenopausal osteoporosis.

Jon C. Ogg
April 25, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.